MIRA INFORM REPORT

 

 

Report Date :

03.07.2007

 

IDENTIFICATION DETAILS

 

Name :

TYCO HEALTHCARE PTE LTD

 

 

Registered Office :

26 Ang Mo Kio Industrial Park 2, # 04-01, Singapore – 569507

 

 

Country :

Singapore

 

 

Financials (as on) :

30.09.2005

 

 

Date of Incorporation :

03/02/1998

 

 

Com. Reg. No.:

199800515M

 

 

Legal Form :

Pte Ltd

 

 

Line of Business :

Marketing and Distribution of Medical Products and Equipment

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 


Subject Company  

 

TYCO HEALTHCARE PTE LTD

 

 

Line Of Business 

 

MARKETING AND DISTRIBUTION OF MEDICAL PRODUCTS AND EQUIPMENT

 

                    

Parent Company    

 

TYCO GROUP S. A. R. L

(PERCENTAGE OF SHAREHOLDING: 100.00%)

 

 

Financial Elements

 

                                      FY 2005                 

                                      COMPANY

Sales                            : USD110,555,784

Networth                                   : USD22,932,826

Paid-Up Capital                                     : USD11,214,000

Net result                      : USD2,667,347

 

Net Margin(%)               : 2.41

Return on Equity(%)       : 11.63

Leverage Ratio               : 3.23

 

 


COMPANY IDENTIFICATION

 

Subject Company:                  TYCO HEALTHCARE PTE LTD

Former Name:                        KENDALL MEDICAL FAR EAST PTE LTD

Business Address:                 26 ANG MO KIO INDUSTRIAL PARK 2

                                                # 04-01

Town:                                      SINGAPORE  

Postcode:                                569507

County:                                                            -

Country:                                                          Singapore

Telephone:                              6482 0100  

Fax:                                         6482 0779/ 6482 0300

ROC Number:                        199800515M   

Reg. Town:                             -

 

 

PREVIOUS IDENTIFICATION

 

KENDALL MEDICAL FAR EAST PTE LTD    DATE OF CHANGE OF NAME: 28/07/1999

 

 

SUMMARY

 

All amounts in this report are in:                   USD unless otherwise stated

Legal Form:                                                    Pte Ltd

Date Inc.:                                                                                03/02/1998

Previous Legal Form:                                    -

Summary year:                                                30/09/2005    

Sales:                                                                                      110,555,784 

Net worth:                                                       22,932,826  

Capital:                                                                                   24,000,000    

Paid-Up Capital:                                            11,214,000  

Employees:                                                     Not available

Net result:                                                                               2,667,347  

Share value:                                                    1  

Auditor:                                                                                   DELOITTE & TOUCHE

 

 

REFERENCES

 

Litigation:                                                        No

Company status:                     TRADING 

Started:                                                           03/02/1998

 

 

PRINCIPAL(S)

 

LIM CHWEE LAN SERENE                         S1354912E      Director

 

 

DIRECTOR(S)

 

WALTER TARCA                                                                                          S2726133G      Director

Appointed on:                          20/02/2001

Street:                                     2 KIM SENG WALK

                          #31-07

Town:                                      SINGAPORE

Postcode:          239404

Country:                                  Singapore

 

TEO TECK CHONG EDMUND                                          S6963454J      Director

Appointed on:                          10/12/2003

Street:                                     173 CHIN SWEE ROAD

                          #14-04

                          LANDMARK TOWER

Town:                                      SINGAPORE

Postcode:          169878

Country:                                  Singapore

 

LIM CHWEE LAN SERENE                                                 S1354912E      Director

Appointed on:                          10/12/2003

Street:                                     41A BEDOK RIA CRESCENT

                          #02-53

                          STRATFORD COURT

Town:                                      SINGAPORE

Postcode:          489929

Country:                                  Singapore

 

THAM MAY CHENG                                                            S2565810H      Company Secretary

Appointed on:                          01/03/2005

Street:                                     234 HOUGANG AVENUE 1

                          #04-260

Town:                                      SINGAPORE

Postcode:          530234

Country:                                  Singapore

 

CHOONG HWEI FONG                                                       S7084489C      Company Secretary

Appointed on:                          01/03/2005

Street:                                     320 ANG MO KIO AVENUE 1

                          #03-1515

Town:                SINGAPORE

Postcode:          560320

Country:            Singapore

 

 

FORMER DIRECTOR(S)

 

GAVAN MATTHEW FOX                                                     F5646863M

 

LOH LEE ENG                                                                       S1289585B

 

ABDUL JABBAR BIN KARAM DIN                                     S6936625B

 

RICHARD JOSEPH MEELIA                                              140768506

 

 

ACTIVITY(IES)

 

SCIENTIFIC APPARATUS And INSTRUMENTS             Code:19027

 

MEDICAL ELECTRONICS                                                  Code:13650

 

BASED ON ACRA'S RECORD AS AT 28/06/2007

 

1) ACTIVITIES NOT ADEQUATELY DEFINED; MARKETING & DISTRIBUTION OF MEDICAL PRODUCTS & EQUIPMENT

 

 

CHARGES

 

No Charges On Premises/Property In Our Database

 

 

PREMISES/PROPERTY INFORMATIONS

 

No Premises/Property Information In Our Databases

 

 

BANKERS

 

CITIBANK N.A.

 

 

SHAREHOLDERS(S)

 

TYCO GROUP S. A. R. L                           19,211,234   Company

Street:                                     17 BOULEVARD GRANDE DUCHESSE CHARL

                          OL-1331,LUXEMBOURG

Town:                                      -

Postcode:                                -

Country:                                  United States

 

 

HOLDING COMPANY

 

TYCO GROUP S. A. R. L                   UF24007W        %: 100  

 

 

SUBSIDIARY(IES)

 

TYCO HEALTHCARE (ISRAEL) LTD

 

 

PAYMENT HISTORY AND EXPERIENCES

 

Trade Morality:                       AVERAGE

Liquidity:                                                         SUFFICIENT

Payments:                               REGULAR

Trend:                                                             DOWNWARD

Financial Situation:                AVERAGE

 

 

LITIGATION(S)

 

No Litigation In Our Database

 

 

FINANCIAL ELEMENTS

 

All amounts in this report are in: USD unless otherwise stated

 

  Audit Qualification: UNQUALIFIED (CLEAN)  UNQUALIFIED (CLEAN)  UNQUALIFIED (CLEAN)

  Date Account Lodged:         07/04/2006

  Balance Sheet Date:          30/09/2005           30/09/2004            30/09/2003

  Number of weeks:                     52                   52                    52

  Consolidation Code:             COMPANY              COMPANY               COMPANY

 

                         --- ASSETS    

 

  Preliminary Exp                 116,212              199,212                  -           

  Tangible Fixed Assets:        1,763,244              838,736             1,684,911  

  Investments                  10,714,000           10,714,000            18,549,915  

  Total Fixed Assets:          12,593,456           11,751,948            20,444,826

 

  Inventories:                 12,072,233           18,725,571            28,057,420  

  Receivables:                 42,516,644           35,182,837            46,407,376  

  Cash,Banks,Securities:          354,748              229,504               172,601  

  Other current assets:        29,387,768           17,419,473            17,877,665  

  Total Current Assets:        84,331,393           71,557,385            92,515,062  

 

  TOTAL ASSETS:                96,924,849           83,309,333           112,959,888  

 

                         --- LIABILITIES    

 

  Equity capital:              11,214,000           11,214,000            19,211,234  

  Profit & loss Account:       11,718,826            9,051,479             9,125,270  

  Total Equity:                22,932,826           20,265,479            28,336,504 

 

  Other long term Liab.:        5,909,061            5,895,000            10,040,017  

  Total L/T Liabilities:        5,909,061            5,895,000            10,040,017  

 

  Trade Creditors:             61,512,342           52,303,659            66,657,272

  Prepay. & Def. charges:       2,979,947            2,350,474                  -               

  Provisions:                   1,286,869            1,303,078               827,390

  

  Other Short term Liab.:       2,303,804            1,191,643             7,098,705   

  Total short term Liab.:      68,082,962           57,148,854            74,583,367  

 

  TOTAL LIABILITIES:           73,992,023           63,043,854            84,623,384  

 

PROFIT & LOSS ACCOUNT    

 

  Net Sales                      110,555,784          95,591,922         147,851,512

  Purchases,Sces & Other Goods:   86,109,408          72,411,919                -                

  Gross Profit:                   24,446,376          23,180,003          35,437,159  

  Result of ordinary operations    3,407,767           4,685,061           7,320,638  

  NET RESULT BEFORE TAX:           3,210,708           4,572,832           6,920,413  

  Tax:                               543,361             651,107             613,935  

  Net income/loss year:            2,667,347           3,921,725           6,306,478  

  Interest Paid:                     197,059             112,229             781,492  

  Depreciation:                      509,853             456,403             810,239  

  Directors Emoluments:              936,358             774,598             780,304  

  Wages and Salaries:              5,337,809           4,983,466           7,634,332

  

 

RATIOS

 

                                   30/09/2005           30/09/2004          30/09/2003

  Net result / Turnover(%):            0.02                 0.04                0.04

  Fin. Charges / Turnover(%):          0.00                 0.00                0.01

  Stock / Turnover(%):                 0.11                 0.20                0.19

  Net Margin(%):                       2.41                 4.10                4.27

  Return on Equity(%):                11.63                19.35               22.26

  Return on Assets(%):                 2.75                 4.71                5.58

  Net Working capital:          16248431.00          14408531.00         17931695.00

  Cash Ratio:                          0.01                 0.00                0.00

  Quick Ratio:                         0.63                 0.62                0.62

  Current ratio:                       1.24                 1.25                1.24

  Receivables Turnover:              138.45               132.50              113.00

  Leverage Ratio:                      3.23                 3.11                2.99

 

  Net Margin: (100*Net income loss year)/Net sales 

  Return on Equity: (100*Net income loss year)/Total equity

  Return on Assets: (100*Net income loss year)/Total fixed assets

  Net Working capital: (Total current assets-Total short term liabilities)

  Cash Ratio: Cash Bank securities/Total short term liabilities

  Quick Ratio: (Cash Bank securities+Receivables)/Total Short term liabilities

  Current ratio: Total current assets/Total short term liabilities

  Inventory Turnover: (360*Inventories)/Net sales 

  Receivables Turnover: (Receivable*360)/Net sales 

  Leverage Ratio: Total liabilities/(Total equity-Intangible assets)

 

 

FINANCIAL COMMENTS

 

THE FINANCIAL CONDITION OF THE COMPANY WAS SEEN TO BE FAIR TO STABLE IN VIEW OF THE FOLLOWING:

 

NET WORTH:

THE BALANCE SHEET WAS CONSIDERED PASSABLE WITH NET WORTH IMPROVED BY 13.16% FROM USD20,265,479 IN 2004 TO USD22,932,826 IN 2005.

 

THIS WAS DUE TO HIGHER ACCUMULATED PROFITS OF USD11,718,826 (2004: USD9,051,479); A RISE OF 29.47% FROM THE PRIOR FINANCIAL YEAR.

 

LEVERAGE:

IN THE SHORT-TERM, SUBJECT WAS LARGELY FINANCED BY TRADE CREDITORS WHICH MADE UP 90.35% (2004: 91.52%) OF THE TOTAL CURRENT LIABILITIES AND AMOUNTED TO USD61,512,342 (2004: USD52,303,659). THE BREAKDOWN IS AS FOLLOWS:

-OUTSIDE PARTIES - 2005: USD298,394 (2004: USD254,118)

-RELATED COMPANIES - 2005: USD61,213,948 (2004: USD52,049,541)

 

SUBJECT'S LONG TERM LIABILITY, WHICH CONSIST OF LOAN FROM A RELATED COMPANY, ROSE BY 0.24% TO USD5,909,061 (2004: USD5,895,000).

 

IN ALL, LEVERAGE RATIO ROSE FROM 3.11 TIMES TO 3.23 TIMES AS A RESULT OF A MORE THAN PROPORTIONATE RISE IN TOTAL LIABILITIES AS COMPARED TO THE RISE IN TOTAL EQUITY.

 

LIQUIDITY:

IN GENERAL, SUBJECT'S LIQUIDITY SITUATION WAS PASSABLE AS SEEN FROM THE RISE IN NET WORKING CAPITAL BY 12.77% TO USD16,248,431 (2004: USD14,408,531).

 

SIMILARLY, CASH AND CASH EQUIVALENTS ROSE SHARPLY BY 54.57% TO USD354,748

(2004: USD229,504).

 

CURRENT RATIO FELL TO 1.24 TIMES, DOWN FROM 1.25 TIMES BUT QUICK RATIO IMPROVED TO 0.63 TIMES FROM 0.62 TIMES IN 2004.

 

PROFITABILITY:

REVENUE POSTED AN INCREASE OF 15.65% FROM USD95,591,922 IN 2004 TO USD110,555,784 BUT NET PROFIT DROPPED BY 31.99% TO USD2,667,347 (2004: USD3,921,725).

 

THIS COULD BE DUE TO LOWER GROSS MARGIN OF 22.11% IN 2005 (2004: 24.25%).

 

HENCE, NET MARGIN FELL TO 2.41% (2004: 4.10%).

 

DEBT SERVICING:

DEBT SERVICING PROBLEMS MIGHT NOT BE EXPECTED IF REVENUE AND EARNINGS CAN BE MAINTAINED AND PAYMENT BY TRADE DEBTORS ARE FORTHCOMING. IN ADDITION, ITS INTEREST COVERAGE WAS HEALTHY AS SHOWN BY ITS INTEREST COVERAGE RATIO OF 17.29 TIMES

(2004: 41.75 TIMES).

 

NON-CURRENT ASSETS:

THE FOLLOWING ITEM IS CLASSIFIED UNDER PRELIMINARY:

-DEFERRED TAX ASSET - 2005: USD116,212 (2004: USD199,212)

 

NOTES TO THE FINANCIAL STATEMENTS:

 

CONTINGENT LIABILITIES

 

BANKERS GUARANTEES (UNSECURED) - 2005: USD538,472 (2004: USD46,053)

 

 

BACKGROUND/OPERATION

 

THE SUBJECT WAS INCORPORATED IN THE REPUBLIC OF SINGAPORE ON 03/02/1998 AS A LIMITED PRIVATE COMPANY UNDER THE FORMER NAMESTYLE OF "KENDALL MEDICAL FAR EAST PTE LTD".

 

SUBSEQUENTLY ON 28/07/1999, SUBJECT CHANGED TO ITS PRESENT NAMESTYLE OF "TYCO HEALTHCARE PTE LTD".

 

AS AT 28/06/2007, THE COMPANY HAS AN ISSUED AND PAID-UP CAPITAL OF 19,211,234 SHARES, OF A VALUE OF S$19,211,234.

 

PRINCIPAL ACTIVITIES:

SUBJECT IS REGISTERED WITH THE ACCOUNTING AND CORPORATE REGULATORY AUTHORITY (ACRA) BE PRINCIPALLY ENGAGED IN THE BUSINESS OF:

1) ACTIVITIES NOT ADEQUATELY DEFINED; MARKETING & DISTRIBUTION OF MEDICAL PRODUCTS & EQUIPMENT

 

DURING THE FINANCIAL YEAR UNDER REVIEW, THE PRINCIPAL ACTIVITIES OF THE COMPANY CONSIST OF THE MARKETING AND DISTRIBUTION OF MEDICAL PRODUCTS AND EQUIPMENT.

 

FROM THE RESEARCH DONE, THE FOLLOWING INFORMATION WAS GATHERED:

 

BACKGROUND

 

ACTIVITIES:

* WHOLESALING OF MEDICAL EQUIPMENTS AND MEDICAL PRODUCTS

* IMPORTER AND TRADING OF MEDICAL EQUIPMENT AND MEDICAL PRODUCTS

 

BUSINESS SEGMENTS:

* MEDICAL, SURGICAL, RESPIRATORY, IMAGING, PHARMACEUTICAL AND RETAIL PRODUCTS

 

MEDICAL PRODUCTS:

* WOUND CARE, INCONTINENT CARE, NURSING CARE, VASCULAR COMPRESSION, SHARPS/NEEDLES

  & SYRINGES, ELECTRODES.

 

BRAND(S):

* J.T. BAKER

* KENDALL

* MALLINCKRODT

* US SURGICAL

* VALLEYLAB

* MOTHERMATES

* PURITAN BENNETT

 

PURCHASES:

* IMPORTS (%): NOT AVAILABLE

* TERMS OF IMPORT: 30 DAY TERMS, ETC

* IMPORT COUNTRIES: UNITED STATES, ETC

 

MARKETS

* LOCAL (%): NOT AVAILABLE

* TERMS SALES: 30 DAY TERMS, ETC

* EXPORT(%): NOT AVAILABLE

* TERMS OF EXPORT: 30 DAY TERMS, ETC

* EXPORT COUNTRIES: ASIA PACIFIC REGION; BRUNEI, INDONESIA, WEST MALAYSIA (SELANGOR), ETC

 

SPONSOR FOR:

* NEPHRO ASIA 2006

 

AWARDS:

* BHQ AWARD (BUSINESS HEADQUARTERS AWARD BY SINGAPORE ECONOMIC DEVELOPMENT BOARD)

 

SUBJECT IS A MEMBER OF FOLLOWING ENTITIES:

* SINGAPORE MANUFACTURERS' FEDERATION (SMA)

* AUSTRALIAN CHAMBER OF COMMERCE

 

NO OTHER TRADE INFORMATION WAS MADE AVAILABLE AT THE TIME OF THIS REPORT.

 

THE COMPANY IS A SUBSIDIARY OF TYCO GROUP S.A.R.L, INCORPORATED IN LUXEMBOURG. THE COMPANY'S ULTIMATE HOLDING COMPANY IS TYCO INTERNATIONAL LTD, INCORPORATED IN BERMUDA.

 

NUMBER OF EMPLOYEES (30 SEPTEMBER)

- COMPANY: 2005: NOT AVAILABLE (2004: 103; 2003: 127; 2002: 98)

 

REGISTERED & BUSINESS ADDRESS:

26 ANG MO KIO INDUSTRIAL PARK 2

#04-01

SINGAPORE 569507

DATE OF CHANGE OF ADDRESS: 07/07/2000

- OFFICE

 

REPRESENTATIVE OFFICE IN MALAYSIA:

SUITE A.17.1 MENARA ATLAS

PLAZA PANTAI

NO.5 JALAN 4/83A,

OFF JALAN PANTAI BARU

59200 KAULA LAMPUR

PHONE: 603-2297-6000

FAX: 603-2297-6100

 

REPRESENTATIVE OFFICE IN PHILIPPINES:

UNIT 24-E, 24TH FLOOR,

CITY BANK TOWER, PASEO DE ROXAS

MAKATI CITY,

PHILIPPINES

PHONE: 632-848-0206

FAX: 632-848-0207

 

EMAIL:

walter.tarca@tycohealth.com.au

ContactUs@tycohealth.com.sg

 

WEBSITE:

http://www.tycohealthcare.com

http://www.tycohealthcareasia.com

 

MANAGEMENT

 

THE DIRECTORS AT THE TIME OF THIS REPORT ARE:

 

1) TEO TECK CHONG EDMUND, A SINGAPORE PERMANENT RESIDENT

- HOLDS NO OTHER DIRECTORSHIPS AS RECORDED IN OUR DATABASE.

 

2) LIM CHWEE LAN SERENE, A SINGAPOREAN

- HOLDS NO OTHER DIRECTORSHIPS AS RECORDED IN OUR DATABASE.

 

3) WALTER TARCO, A SINGAPORE PERMANENT RESIDENT

- HOLDS NO OTHER DIRECTORSHIPS AS RECORDED IN OUR DATABASE.

 

 

SINGAPORE’S COUNTRY RATING 2007

 

INVESTMENT GRADE

 

IN SINGAPORE, THE POLITICAL SITUATION REMAINS STABLE.

 

SINGAPORE BOASTS THE BEST GOVERNANCE IN ASIA, WITH AN EFFECTIVE LEGAL SYSTEM FACILITATING DEBT COLLECTION AND TO A HIGH DEGREE OF FINANCIAL TRANSPARENCY.

 

EXTERNAL ACCOUNTS HAVE REMAINED SUBSTANTIALLY IN SURPLUS, CONTRIBUTED TO THE DYNAMISM OF THE ELECTRONICS AND PHARMACEUTICALS SECTORS AND TO REPATRIATION OF PROFITS FROM SINGAPORE INVESTMENTS. THE FINANCIAL AND TOURISM SECTORS HAVE ALSO CONTRIBUTED TO THE LARGE CURRENT ACCOUNT SURPLUS.

 

SINGAPORE CONTINUES TO KEENLY WELCOME FOREIGN INVESTMENT AND OFFERS A VERY OPEN AND WELL-PLANNED ECONOMIC AND POLITICAL ENVIRONMENT. IT HAS BEEN IMPLEMENTING AMBITIOUS DIVERSIFICATION STRATEGY, FOCUSED PARTICULARLY ON THE CHEMICALS AND PHARMACEUTICAL SECTORS.

 

THE GOVERNMENT USES FOREIGN DIRECT INVESTMENT TO DEVELOP PRIORITY SECTORS (ELECTRONICS, CHEMICALS, BIOTECHNOLOGY). THE AIM IS TO ENCOURAGE THE GROWTH OF HIGH ADDED-VALUE ACTIVITIES AND TURN SINGAPORE INTO A REGIONAL HUB FOR FOREIGN INVESTORS INTERESTED IN ASIA.

 

CERTAIN SECTORS (MEDIA, LEGAL AND FINANCIAL SERVICES) ARE HOWEVER ONLY PARTIALLY OPEN TO FOREIGN INVESTMENT. THESE SECTORS ARE SLOWLY OPENING UP, BUT THE PROGRESS IS SLOW. AFTER HIGH GROWTH IN 2006, BUOYED BY THE DYNAMISM OF BOTH EXPORTS AND HOUSEHOLD CONSUMPTION, A SLOWDOWN IS EXPECTED IN 2007.

 

ASSETS

" MAJOR EXPORTER OF CAPITAL IN ASIA, NOTABLY VIA THE STATE-OWNED TEMASEK HOLDING

  COMPANY.

" HIGH QUALITY COMPETITIVENESS IN ASIA

" EXCELLENT BUSINESS CLIMATE

" POLITICAL STABILITY.

 

WEAKNESSES

" SKILLED MANPOWER HAS BEEN LACKING IN THE SECTORS TARGETED FOR DEVELOPMENT.

" AN AGEING POPULATION COULD, ULTIMATELY, AFFECT ECONOMIC PERFORMANCE.

" GROWING INEQUALITY AND THE EMERGENCE OF LONG-TERM UNEMPLOYMENT AMONG THE LEAST

  SKILLED COULD GENERATE SOCIAL TENSIONS.

" BEING THE WORLD'S MOST OPEN ECONOMY, IT HAS BEEN VULNERABLE TO WORLD ECONOMIC

  DOWNTURNS.

 

 

WHOLESALE AND RETAIL TRADE SECTOR

 

PAST PERFORMANCE  

 

DOMESTIC WHOLESALE TRADE INDEX

 

THE OVERALL DOMESTIC WHOLESALE TRADE DECLINED BY 7.5% IN Q1 2007. EXCLUDING PETROLEUM, DOMESTIC SALES FELL BY 7.4%. SECTORS OF ELECTRONIC COMPONENTS, SHIP CHANDLERS AND BUNKERING, INDUSTRIAL AND CONSTRUCTION MACHINERY REPORTED DECLINES OF 11.6% TO 23.8%.

 

HOWEVER, WHOLESALERS OF FOOD, BEVERAGES AND TOBACCO REGISTERED HIGHER TURNOVER OF 5.4%.

 

FOREIGN WHOLESALE TRADE INDEX   

 

THE OVERALL FOREIGN WHOLESALE TRADE IN QUARTER 1 2007 FELL BY 7.6%. EXCLUDING PETROLEUM, FOREIGN SALES DECLINED BY 8.0%. MOST WHOLESALE SECTORS REPORTED LOWER OVERSEAS RECEIPTS IN QUARTER 1 2007 COMPARED TO THE PREVIOUS QUARTER, EXCEPT HOUSEHOLD EQUIPMENT AND FURNITURE SECTOR. SHIP CHANDLERS & BUNKERING REPORTED THE LARGEST DECLINE OF 18.3% IN QUARTER 1 2007, FOLLOWED BY FOOD BEVERAGES & TOBACCO SECTOR OF 17.7%.

 

RETAIL TRADE    

 

THE OVERALL RETAIL SALES ROSE MARGINALLY BY 0.7% IN QUARTER 2 2007, COMPARED TO QUARTER 2 2006. EXCLUDING MOTOR VEHICLES, RETAIL SALES ROSE BY 5.1%. SALES OF OPTICAL GOODS & BOOKS, FURNITURE & HOUSEHOLD EQUIPMENT AND SUPERMARKETS ENJOYED STRONG GROWTHS OVER A YEAR AGO. PROVISION & SUNDRY SHOPS, WATCHES AND JEWELLERY, DEPARTMENT STORES AND WEARING APPAREL & FOOTWEAR SECTORS ALSO REPORTED HIGHER SALES OF 4.35 TO 5.9% RESPECTIVELY.

 

HOWEVER, RETAILERS OF MOTOR VEHICLES, FOOD & BEVERAGES, TELECOMMUNICATIONS APPARATUS & COMPUTERS AND PETROL SERVICES STATIONS REPORTED LOWER SALES.

 

OUTLOOK

 

GENERALLY, WHOLESALERS EXPECT TO DO WELL FOR THE NEXT 6 MONTHS, WITH A POSITIVE NET WEIGHTED BALANCE OF 17%. DEALERS OF FOOD & BEVERAGES, TROPICAL PRODUCE, TEXTILES & LEATHER GOODS AND HOUSEHOLD ELECTRICAL APPLIANCE & EQUIPMENT ARE AMONG THOSE WHO ARE OPTIMISTIC.

 

RETAIL TRADE FIRMS ANTICIPATE BUSINESS TO BE LESS BRISK FOR THE NEXT 6 MONTHS. IN PARTICULAR, DEPARTMENT STORES, SUPERMARKETS AND RETAILERS OF MOTOR VEHICLES EXPECT SLOWER BUSINESS IN THE COMING MONTHS.

 

EXTRACTED FROM: MINISTRY OF TRADE AND INDUSTRY, SINGAPORE

                      SINGAPORE DEPARTMENT OF STATISTICS

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions